Pharmafile Logo
Pharmafocus logo
Advanced Search
6123892769_1befc31f38_o

GSK ‘in discussions’ over $1 billion tech deal with Qualcomm

January 21, 2016
Medical Communications GSK, beyond the pill, digital pharma, joint venture, qualcomm

GlaxoSmithKline and telecoms giant Qualcomm are reportedly discussing a joint venture agreement worth as much as $1 billion, as the …

News
China pharmacy

Five charged in US for scheme to steal GSK secrets

January 21, 2016
Research and Development China, GSK, employee theft, trade secrets

Five people have been charged in the US for a scheme to steal secrets from British drugmaker GlaxoSmithKline and then …

News
WEF

Pharma leads global call for action on antimicrobial resistance

January 21, 2016
Manufacturing and Production, Research and Development Davos, Lord Jim O'Neill, Review on antimicrobial resistance, World Economic Forum, antibiotic resistance, antimicrobial resistance

More than 70 leading international pharmaceutical and biotechnology companies, as well as industry associations, have come together to call for …

News
GAVI logo

MSD and GAVI agree Ebola vaccine deal

January 20, 2016
Manufacturing and Production, Research and Development Ebola, GAVI, MSD, WHO

MSD and the global vaccine alliance Gavi have agreed a deal to provide 300,000 dosesof  an Ebola virus vaccine, to …

News
eli_lilly_logo

Lilly awaits FDA review of new arthritis treatment

January 20, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Eli Lilly, FDA, Incyte, NDA, baricitinib, lilly, new drug application, rheumatoid arthritis

Eli Lilly has submitted a new drug application (NDA) to the FDA for baricitinib as a treatment for moderate-to-severe rheumatoid …

News
Arzerra

Arzerra approved by US FDA for leukaemia

January 20, 2016
Research and Development, Sales and Marketing Afrezza, CLL, FDA, Genmab, Novartis, chronic lymphocytic leukaemia, ofatumumab, sBLA, supplementary biologics license application

The FDA has signed-off a supplemental Biologics License Application (sBLA), meaning Arzerra is approved for extended treatment of patients who …

News

J&J to cut up to 3,000 jobs in key business unit

January 20, 2016
Manufacturing and Production, Research and Development Jobs, Johnson and Johnson, pharmajobs, redundancies

Johnson & Johnson has announced a restructuring of its medical devices business unit that could result in up to 3,000 …

News
Marisol Touraine

French Health Minister criticises CRO’s slow response to clinical trial accident

January 19, 2016
Manufacturing and Production, Research and Development Bial, Biotrial, Marisol Tourain, clinical trial

Days after the clinical trial accident that left one participant dead and five hospitalised with neurological problems, French Health Minister …

News
China manufacturing

Bayer opens OTC drug plant in China

January 19, 2016
Manufacturing and Production Bayer, China, OTC, TCM, Yunnan, over the counter, traditional Chinese medicine

Bayer has opened a new manufacturing plant to produce over-the-counter (OTC) drugs in China, as the German firm looks to …

News

Alzheimer’s drugs prescriptions rise six-fold in a decade

January 19, 2016
Manufacturing and Production Alzheimer's, Alzheimer's disease, NHSIC, dementia, prescribing

The number of prescriptions dispensed in England for approved medicines to treat Alzheimer’s increased from 502,000 in 2004 to 3 …

News
blood

Sobi launches new haemophilia treatment in UK

January 19, 2016
Manufacturing and Production, Sales and Marketing elocta, haemophilia a, sobi

Swedish Orphan Biovitrum Ltd (Sobi) has launched its haemophilia A treatment Elocta (efmoroctocog alfa) in the UK, following its EU …

News
merck_logo_small

Merck appoints new executive board members

January 19, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck

Merck has appointed two new members to its executive board: Udit Batra (45), head of the Life Science business sector, …

Appointment
stephen_stamp

Ergomed announces board changes

January 19, 2016
Manufacturing and Production, Research and Development, Sales and Marketing ergomed, primevigilance

Ergomed, a specialist provider of drug development services to the pharmaceutical industry, has announced that Neil Clark, current chief financial …

Appointment
Eisai logo

FDA grants Eisai’s Lenvima priority review for kidney cancer

January 19, 2016
Manufacturing and Production Breakthrough Therapy Designation, Eisai, FDA, Kidney cancer, Lenvima, lenvatinib, priority review, renal cell carcinoma

The FDA has accepted Eisai’s supplemental New Drug Application (sNDA) for its anti-cancer agent Lenvima for use in the treatment …

News

Samsung beats pharma to develop first EU-approved Enbrel biosimilar

January 18, 2016
Manufacturing and Production Benepali, CHMP, EMA, Enbrel, Samsung, Samsung Bioepis, etanercept, positive opinion

Samsung Bioepis – the collaboration between Samsung Biologics and Biogen Idec, has become the first company to have a biosimilar …

News
FDA sign

FDA criticised for safety data flaws

January 18, 2016
Sales and Marketing FDA, US Government Accountability Office, pharmacovigilance, post-marketing data, safety

The US FDA is failing to meet its ‘statutorily required’ obligations to track safety data for drugs post-marketing and publish …

News
cosentyx

Two new US approvals for Novartis’ Cosentyx

January 18, 2016
Research and Development, Sales and Marketing Cosentyx, Novartis

Novartis has won FDA approval for Cosentyx (secukinumab) for the treatment of two new indications – adults with active ankylosing …

News
eye_iris

Blow for Eleven Biotherapeutics as eye drug fails in late-stage trial

January 18, 2016
Research and Development, Sales and Marketing Eleven Biotherapeutics, allergic conjunctivitis, isunakinra

A study by Eleven Biotherapeutics to prove the clinical value of its eye drug isunakinra has flopped, after the drug …

News
biotrial_facility_rennes

Man left brain dead after clinical trial dies in hospital

January 18, 2016
Research and Development, Sales and Marketing Bial, Biotrial, clinical trial

A man left brain dead after a clinical trial in France has died in hospital and five remain in a …

News
Merck MSD

MSD sues German Merck for using name in US

January 15, 2016
Medical Communications, Sales and Marketing MSD, Merck

MSD says it is filing a lawsuit against the German company Merck “regarding their improper use of the name ‘Merck’ …

News
The Gateway to Local Adoption Series

Latest content

SMC accepts amivantamab and lazertinib for EGFR-positive lung cancer

May 22, 2026

BioDuro and CTI Biotechnology in preclinical drug development partnership

May 21, 2026

Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology

May 21, 2026

NICE recommends sotatercept for pulmonary arterial hypertension

May 20, 2026

Vetter begins construction of new injectable medicines facility

May 20, 2026